반응 #1912875

ord-e2b222811baf4d4a886cc0be4c38af81

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타were prepared
  2. 2
    기타Pre-spray drying solutions
  3. 3
    기타were prepared
  4. 4
    농축Final total solute concentration of the solution
  5. 5
    기타drying
  6. 6
    기타was prepared
  7. 7
    workup.ADDITIONmixing the two solutions
  8. 8
    기타to yield one liter of cosolvent with a total solute concentration of 1 g/L (w/v)
  9. 9
    농축Higher solute concentrations of 3 g/L (w/v)
  10. 10
    기타were prepared
  11. 11
    기타The solution was spray-dried
  12. 12
    workup.ADDITIONcontaining formulation
  13. 13
    기타was from about 110° C. to about 140° C.
  14. 14
    기타ranged from about 45–57° C.

실험 절차

The albuterol sulfate powder formulations listed in Table 7, were prepared as follows. Pre-spray drying solutions were prepared by dissolving the lipid in ethanol and albuterol sulfate and leucine in water. The ethanol solution was then mixed with the water solution at a ratio of 70/30 ethanol/water. Final total solute concentration of the solution used for spray drying varied from 1 g/L to 3 g/L. As an example, the DPPC/leucine/albuterol sulfate (76/16/8) spray drying solution was prepared by dissolving 760 mg of DPPC in 700 mL of ethanol, dissolving 160 mg leucine and 870 mg of albuterol sulfate in 300 mL water and then mixing the two solutions to yield one liter of cosolvent with a total solute concentration of 1 g/L (w/v). Higher solute concentrations of 3 g/L (w/v) were prepared by dissolving three times more of each solute in the same volumes of ethnaol and water. The solution was spray-dried as described above for the insulin containing formulation. Specifically, the inlet temperature was from about 110° C. to about 140° C., and the outlet temperature ranged from about 45–57° C.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US07048908B2uspto-grants-2006_05